April 5, 2019

PharmetRx has entered into a research collaboration agreement with Afecta Pharmaceuticals to interrogate promising drug molecules for the treatment of advanced melanoma using the PharmetRx® AI-based drug discovery and development platform. Dr. Feng Liu-Smith, an Assistant Professor in the Department of Epidemiology at UCI, and Dr. John Schomberg, the Director of Bioinformatics at Afecta Pharmaceuticals, will be spearheading this collaborative effort.